aHUS Nomenclature: Bridges to the Future
Scientific advancements in the last decade have yielded promising avenues on multiple fronts, including those related to atypical HUS and other…
Scientific advancements in the last decade have yielded promising avenues on multiple fronts, including those related to atypical HUS and other…
The Struggle of Meal Planning in Families with a Kidney Patient When a family member has a rare kidney disease, meal…
Since its inception in 2008, and celebrated annually on the last day of February, world Rare Disease Day has been an…
It’s largely wishful thinking that an illness can become ‘extinct’ across the human population, as evidenced by the resurgence of diseases…
It’s largely wishful thinking that an illness can become ‘extinct’ across the human population, as evidenced by the resurgence of diseases…
Informação Salva Vidas - SHUa A informação para pacientes brasileiros com SHUa era quase tão rara quanto a própria doença, mas…
After years of waiting, eculizumab Soliris(R) has been approved by India’s Central Drugs Standard Control Organisation (CDSCO) as an approved drug…
It’s been a busy 4th quarter to round out 2024 for our aHUS Alliance Global Action team, and we’d like to…
Artigo Convidado: Pamela Notario Guest Article: by Pamela Notario (English Version below Portuguese Version) É com grande alegria que lançamos a…